Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations
EMBRACE
2 other identifiers
interventional
48
1 country
1
Brief Summary
Understanding the impact exercise has on a cancer survivor's gut microbiome can improve the health and well-being of cancer survivors by enhancing treatments targeting the gut microbiome. Although scientific studies support a link between exercise and the gut microbiome, rigorous randomized trials needed to confirm this causal link are limited and usually involve supervised exercise. Hence, this proposal tests feasibility of a home-based, remote-only research protocol that is more accessible to cancer survivors unable to attend supervised exercise including but not limited to rural populations. This study will also determine if exercise effects on the gut microbiome differ by factors such as race.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2021
CompletedFirst Posted
Study publicly available on registry
August 11, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedMarch 22, 2024
March 1, 2024
2.4 years
August 3, 2021
March 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Feasibility - Recruitment
Number of participants excluded or not agreeing to participate will be measured
Baseline
Feasibility - Adherence to study protocol activities
Feasibility measure (e.g. percent of assessments and intervention sessions completed
Throughout 10 week study period
Feasibility - Attrition rates
Feasibility measure of the number of participants who dropout or are withdrawn
Throughout 10 week study period
Feasibility - Adverse events
Feasibility measure of the number of adverse events recorded by staff during the study period
Throughout 10 week study period
Feasibility - Participant satisfaction
Self-Administered survey given to the participant at the conclusion of the 10 week study period
At conclusion of 10 week study period
Secondary Outcomes (33)
Accelerometer Measured Free-living physical activity (e.g., minutes of activity)
Baseline
Accelerometer Measured Free-living physical activity (e.g., minutes of activity)
5 weeks after baseline
Accelerometer Measured Free-living physical activity (e.g., minutes of activity)
10 weeks after baseline
Body fat percentage analysis using a Tanita bioelectrical impedance analysis scale
Baseline
Body fat percentage analysis using a Tanita bioelectrical impedance analysis scale
5 weeks after baseline
- +28 more secondary outcomes
Study Arms (2)
Home-based aerobic exercise training
EXPERIMENTALhome-based aerobic exercise condition will receive a fitness bracelet (with heart rate measurement capability) and weekly exercise counseling from an exercise trainer (i.e., exercise physiologist) by videoconference. The weekly counseling will be guided by the fitness bracelet data (both participant and exercise trainer will share the same log in information). The aerobic exercise progression will gradually increase duration and intensity of aerobic exercise with the goal of improving cardiorespiratory fitness.
Home-based standard attention flexibility/toning control
ACTIVE COMPARATORHome-based standard attention flexibility/toning control will receive light resistance bands, stretching/toning log book, and weekly videoconference counseling from an exercise trainer.
Interventions
A 10-week home-based exercise intervention including weekly video conferences with exercise specialists.
Eligibility Criteria
You may qualify if:
- Non-Hispanic white or black women
- Age 18-70 years
- History of breast cancer stage 0, I, II, or III
- ≥1 year post-primary cancer treatment completion
- English speaking
- Ambulates without assistance
- No antibiotics in past 90 days
- Willing to avoid taking probiotics during the study
- Has access to a safe place to perform aerobic exercise (e.g., willing to walk in neighborhood or has gym membership or owns relevant exercise equipment at home, etc.)
- Has access to good internet and WIFI and device capable of videoconferencing (the study has limited resources to loan tablets and hotspots)
You may not qualify if:
- Metastatic or recurrent cancer
- Another cancer diagnosis in the past 5 years (not including skin or cervical cancer in situ)
- Unstable angina
- New York Heart Association class II, III, or IV congestive heart failure
- Uncontrolled asthma
- Interstitial lung disease
- Current steroid use
- Told by a physician to only do exercise prescribed by a physician
- Dementia or organic brain syndrome
- Schizophrenia or active psychosis
- Connective tissue or rheumatologic disease
- Participating in \>30 minutes of exercise on ≥3 days/week in the past six months
- Anticipate elective surgery, medication changes or antibiotics during the study
- Contraindication to ≥moderate intensity aerobic exercise
- Physical limitations that prevent engaging in ≥moderate intensity aerobic exercise
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Rogers, MD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Staff doing assessments will be masked to study group allocation
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Med - Preventive Medicine
Study Record Dates
First Submitted
August 3, 2021
First Posted
August 11, 2021
Study Start
September 1, 2021
Primary Completion
January 22, 2024
Study Completion
January 31, 2024
Last Updated
March 22, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share participant data.